Affinity
Pudong
About Affinity
Affinity Biomedical Technology is a clinical biopharmaceutical company focusing on the development of global innovative anticancer drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $97.1M
- Funding stage: Early Stage Venture
- Last round: Series B (Sep 2025)
- Website: affinitybiopharma.comenindex.html
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Canonical: https://fsome.com/organization/affinity-90653 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.